TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.220nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 86nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 206nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 1.47E+3nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.10nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.90nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 164nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 395nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 444nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.03E+3nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >2.50E+3nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha'/beta(Homo sapiens (Human))
Cylene Pharmaceuticals
Curated by ChEMBL
Cylene Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >2.50E+3nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair